Steatosis decreases significantly following successful antiviral treatment for chronic hepatitis C infection.

被引：0
|
作者：
Patton, HM
Behling, C
Patel, K
Pockros, PJ
Heaton, S
Blatt, LM
McHutchison, JG
机构：
[1] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA
[2] Scripps Clin, La Jolla, CA USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
470
引用
收藏
页码：280A / 280A
页数：1
相关论文
共 50 条
  • [41] Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection
    Ikezawa, K.
    Naito, M.
    Yumiba, T.
    Iwahashi, K.
    Onishi, Y.
    Kita, H.
    Nishio, A.
    Kanno, T.
    Matsuura, T.
    Ono, A.
    Chiba, M.
    Mizuno, T.
    Aketa, H.
    Maeda, K.
    Michida, T.
    Katayama, K.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (07) : 488 - 492
  • [42] Evolution and emergence of a new era of antiviral treatment for chronic hepatitis C infection
    Lim, T. R.
    Tan, B. H.
    Mutimer, D. J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (01) : 17 - 25
  • [43] Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
    Cho, J-H.
    Lim, J-H.
    Park, G-Y.
    Kim, J-S.
    Kang, Y-J.
    Kwon, O.
    Choi, J-Y.
    Park, S-H.
    Kim, Y-L.
    Kim, H-K.
    Huh, S.
    Kim, C-D.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (02) : 295 - 303
  • [44] α-interferon-2b and ribavirin treatment in children with chronic hepatitis C infection.
    Wirth, S
    Gehring, S
    Gerner, P
    Kullmer, U
    HEPATOLOGY, 2001, 34 (04) : 333A - 333A
  • [45] Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: Evidence for a role of HCV genotype 3 in steatosis
    Castera, L
    Hezode, C
    Roudot-Thoraval, F
    Lonjon, I
    Zafrani, ES
    Pawlotsky, JM
    Dhumeaux, D
    JOURNAL OF HEPATOLOGY, 2003, 38 : 132 - 132
  • [46] A pilot study of etanercept treatment for inhibition of fibrotic progression in chronic hepatitis C infection.
    Marrero, RJ
    Sobhonslidsuk, A
    Mendez, P
    Torres, M
    Bejarano, P
    O'Brien, C
    Schiff, ER
    GASTROENTEROLOGY, 2005, 128 (04) : A719 - A720
  • [47] Ribavirin treatment for immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
    Jaccard, A
    Loustaud, V
    Touati, M
    Vidal, E
    Bordessoule, D
    BLOOD, 2002, 100 (11) : 306B - 306B
  • [48] Antiviral Treatment of Children with Chronic Hepatitis C
    Romanova, S., V
    Zhukova, E. A.
    Kaplina, N. A.
    ALLERGY, ASTHMA AND IMMUNOLOGY: FROM GENES TO CLINICAL APPLICATION: PROCEEDINGS OF THE IV WORLD ASTHMA AND COPD FORUM AND XVI INTERNATIONAL CONGRESS ON REHABILITATION IN MEDICINE AND IMMUNOREHABILITATION, 2011, : 211 - 213
  • [49] Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients
    Ignacio Vargas, Jose
    Pablo Arab, Juan
    Monrroy, Hugo
    Labbe, Pilar
    Sarmiento, Valeska
    Fuster, Felipe
    Barrera, Francisco
    Benitez, Carlos
    Arrese, Marco
    Fuster, Francisco
    Soza, Alejandro
    REVISTA MEDICA DE CHILE, 2017, 145 (10) : 1235 - 1242
  • [50] Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
    Hourigan, LF
    Macdonald, GA
    Purdie, D
    Whitehall, VLJ
    Shorthouse, C
    Clouston, A
    Powell, EE
    HEPATOLOGY, 1999, 29 (04) : 1215 - 1219
12345